On this page
Everolimus
Active ingredient 7 prescription 27 with labelling
Overview
Source: NDC DirectoryIngredient name
EVEROLIMUS
Base moiety
EVEROLIMUS
RxNorm CUI
UNII
9HW64Q8G6G
Medication products
10
Brand names
6
Dosage forms
3
FAERS reports
50,589 · not a risk measure
- Everolimus Powder
- Everolimus B02 Powder
- Everolimus Premix 2 % Powder
- Afinitor everolimus · Tablet
- Afinitor everolimus · Tablet, for Suspension
- Everolimus Tablet
- Everolimus Tablet, for Suspension
- TORPENZ Everolimus · Tablet
- Yulithira Everolimus · Tablet
- Zortress everolimus · Tablet
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Tablet | 5 | Afinitor, Everolimus, TORPENZ, Yulithira … |
| Powder | 3 | Everolimus, Everolimus B02, Everolimus Premix 2 % |
| TABLET, For Suspension | 2 | Afinitor, Everolimus |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |